IDBS and ChemAxon Ltd. Extend Strategic Relationship

GUILDFORD, UNITED KINGDOM and BURLINGTON, MA and BUDAPEST, HUNGARY--(Marketwire - June 01, 2011) - IDBS, a global provider of innovative data management, analytics and modeling solutions, and ChemAxon, a leading provider of cheminformatics software for the life sciences industry, announce today the extension of their relationship.

IDBS is the world’s most advanced R&D data management provider, according to Frost & Sullivan. Its customers are able to collaborate and become more efficient by implementing software which manages process improvement, secures data and integrates information across multiple scientific disciplines. In addition to its established business across pharmaceuticals R&D, IDBS has recently expanded across fine chemicals, petrochemicals and polymer R&D with customers including BASF, Total and CSIRO.

ChemAxon provides chemistry software toolkits and desktop applications including structure based prediction and library enumeration capabilities which are to now be included in IDBS products. By expanding its relationship with ChemAxon, IDBS can now offer customers direct access to extended cheminformatics capabilities from IDBS established chemistry and data management solutions, maintaining its leading edge capability in all areas of chemistry.

IDBS chemistry customers will benefit from a range of new features including: parallel synthesis capability and reaction enumeration, log P and log D calculation, and complete structure-to-name/name-to-structure generation.

“We are pleased to be working more closely with ChemAxon and believe this offers rapid benefits to our current and future customers in chemistry R&D,” said Neil Kipling, Founder and CEO at IDBS. “ChemAxon provides excellent cheminformatics technologies which complement our innovative approach to chemical R&D data management.”

Alex Drijver, CEO of ChemAxon, commented, “We are delighted to see the extension of this relationship with IDBS; it confirms our emphasis on developing partnerships and will bring immediate benefit to the IDBS ChemBook user community.”

About ChemAxon
ChemAxon is a leader in providing cheminformatics software development platforms and applications for the biotechnology, pharmaceutical and agrochemical industries. With core capabilities for structure visualization, search and management, property prediction, virtual synthesis, screening and drug design, ChemAxon focuses upon active interaction with users and software portability to create powerful, cost effective cross platform solutions and programming interfaces to power modern cheminformatics and chemical communication.

About IDBS
IDBS is a global provider of innovative enterprise data management, analytics and modeling solutions. The company’s uniquely sophisticated platform technologies are used by more than 200 pharmaceutical companies, major healthcare providers, global leaders in academic study, and high tech companies to increase efficiency, reduce costs and improve the productivity of industrial R&D and clinical research. IDBS is clearly differentiated by its unique combination of award-winning enterprise technologies and domain knowledge in R&D.

IDBS’ solutions help scientists, hospitals and R&D businesses produce the world’s newest therapeutics, diagnostics and personalized treatments, high-tech materials and consumer products, faster, cleaner engines and fuels, breakthroughs in productive agriculture, healthy, safer food products, and high tech materials and products.

Founded in 1989 and privately held, IDBS is headquartered in Guildford, UK with a direct sales and support presence worldwide. IDBS is a Profit Track 100 company and the recipient of multiple awards including the Frost and Sullivan ‘Enabling Technology’ Award in R&D data management for 2010 and Queen’s Award for International Trade 2011. Further information can be found at www.idbs.com, or follow us on Twitter @IDBSsoftware.


Media enquiries
Danielle Guinebertiere
Communications Director
Tel: +1 908 429 2933
Email: Email Contact

MORE ON THIS TOPIC